Clinical evaluation of siddha drug brahmi nei(internal) and mahavilwathy thylam (external) for attention deficit hyperactivity disorder in childre
Phase 2
Completed
- Conditions
- Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type
- Registration Number
- CTRI/2021/08/035465
- Lead Sponsor
- ational institute of siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Clinically diagnosed as ADHD
Lack of concentration
Talking nonstop
Blurting things out
Frequent jumping from one task to another
Being easily distracted
Hyperactivity
Trouble sitting still
Inability to react to others emotion or feelings
Exclusion Criteria
Criteria other than DSM V
Epilepsy
Cerebral palsy
Autistic spectrum disorder
Auditory and visual processing disorder
Neurodegenerative disorder
Post-traumatic head injury
Post encephalitic disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effectiveness of Brahmi nei (internal) and mahavilwathy thylam (external) for the management of Alathidu sanni (Attention deficit hyperactivity disorder) in children by using conners parents rating scale and conners teachers rating scaleTimepoint: 48 days
- Secondary Outcome Measures
Name Time Method The goal of the treatment is to help the child follow rules, concentration and have good relationships with parents,teachers and peersTimepoint: 48 days